• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthCOVID-19 vaccines

The U.S. administered more COVID shots this week than it has since spring

By
Nicolas Rapp
Nicolas Rapp
and
Erika Fry
Erika Fry
Down Arrow Button Icon
By
Nicolas Rapp
Nicolas Rapp
and
Erika Fry
Erika Fry
Down Arrow Button Icon
November 10, 2021, 5:30 PM ET

After months of slow progress, America’s COVID vaccine drive jolted ahead this week with the nation administering a total of 9 million shots, more than it had administered in one week since spring, according to Jeff Zients, the White House coronavirus response coordinator, who spoke in a press briefing earlier today.

That progress is due in part to the uptake of booster shots—13.4% of vaccinated Americans had received one as of Wednesday, Nov. 10, according to CDC data—as well as the newly eligible cohort of 5- to 11-year-old children (900,000, according to Zients) and others seeking first doses, many to meet vaccine mandates. 

In all, 224.7 million Americans—67.7% of the total population and 79% of those over 12—have gotten at least one COVID shot. Nationwide, 58.5% of the population is fully vaccinated. States and territories with the highest share of fully vaccinated residents include Connecticut, Maine, Massachusetts, Rhode Island, and Vermont with levels that exceed 70%. West Virginia lags the rest of the country at 41.1%.

Booster shots have outnumbered the combined number of first and second doses administered nationally in recent weeks. Of the 26.2 million Americans who have gotten a booster shot, the majority—15.2 million—have been over 65. Nearly a third of all vaccinated seniors have so far gotten a booster dose.

The majority of booster doses—15.3 million—administered have been Pfizer’s product. Most have gone to individuals who initially received the Pfizer vaccine, but roughly 400,000 went to people who had initially received the Moderna vaccine, and 314,000 went to those who had the Johnson & Johnson vaccine.

Community spread of the coronavirus remains high throughout most of the country, according to the CDC, though in states in the Southeast the level is described as moderate to substantial. Hotspots are concentrated in Western states, though the number of new cases reported daily has begun to climb again nationally, with the current average of roughly 75,000 up 6% over the level two weeks ago, according toNew York Times data. Arizona reported the sharpest increase in daily reported cases, up 73% over two weeks ago, followed by New Hampshire. New cases declined most in Idaho, down nearly 40% in the same period. 

More health care and Big Pharma coverage from Fortune:

  • Biden’s vaccine mandate may be tied up in court—but employers shouldn’t wait to enforce it, say legal experts
  • State Farm publicly supports NFL’s Aaron Rodgers after his vaccine comments—while quietly removing most of his ads
  • How Big Bird became the unlikely target of GOP senators
  • Denmark ditched its COVID rules 2 months ago. Now cases are up—and restrictions are coming back
  • Air purifiers and CO2 monitors are the new pencil and paper in classrooms
About the Authors
Nicolas Rapp
By Nicolas RappInformation Graphics Director
LinkedIn icon

Nicolas Rapp is the former information graphics director at Fortune.

See full bioRight Arrow Button Icon
Erika Fry
By Erika Fry
LinkedIn iconTwitter icon
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.